Literature DB >> 27077275

Portal-vein blood samples as a new diagnostic entity for pancreatic cancer.

Christopher G Chapman1, Irving Waxman1.   

Abstract

Entities:  

Keywords:  Pancreatic cancer; biomarkers; circulating tumor DNA; circulating tumor cells; endoscopic ultrasound; portal venous blood

Mesh：

Substances：

Year:  2016        PMID： 27077275     DOI： 10.1080/17474124.2016.1176911

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN： 1747-4124            Impact factor:   3.869


× No keyword cloud information.
  6 in total

1.  Prognostic Implications of Portal Venous Circulating Tumor Cells in Resectable Pancreatic Cancer.

Authors:  Young Hoon Choi; Tae Ho Hong; Seung Bae Yoon; In Seok Lee; Myung Ah Lee; Ho Joong Choi; Moon Hyung Choi; Eun Sun Jung
Journal:  Biomedicines       Date:  2022-05-31

Review 2.  Tumor-proximal liquid biopsy to improve diagnostic and prognostic performances of circulating tumor cells.

Authors:  Etienne Buscail; Laurence Chiche; Christophe Laurent; Véronique Vendrely; Quentin Denost; Jérôme Denis; Matthieu Thumerel; Jean-Marc Lacorte; Aurélie Bedel; François Moreau-Gaudry; Sandrine Dabernat; Catherine Alix-Panabières
Journal:  Mol Oncol       Date:  2019-07-25       Impact factor: 6.603

3.  Role of endoscopic ultrasound in the field of hepatology: Recent advances and future trends.

Authors:  Jahnvi Dhar; Jayanta Samanta
Journal:  World J Hepatol       Date:  2021-11-27

4.  Endoscopic Ultrasound-Guided Acquisition of Portal Venous Circulating Tumor Cells as a Potential Diagnostic and Prognostic Tool for Pancreatic Cancer.

Authors:  Yixuan Zhang; Haochen Su; Haibo Wang; Chenghu Xu; Siqi Zhou; Jing Zhao; Shanshan Shen; Guifang Xu; Lei Wang; Xiaoping Zou; Shu Zhang; Ying Lv
Journal:  Cancer Manag Res       Date:  2021-10-05       Impact factor: 3.989

5.  Pattern Recognition Receptor-reactivity Screening of Liver Transplant Patients: Potential for Personalized and Precise Organ Matching to Reduce Risks of Ischemia-reperfusion Injury.

Authors:  Rebecca A Sosa; Maura Rossetti; Bita V Naini; Victoria M Groysberg; Fady M Kaldas; Ronald W Busuttil; Yu-Ling Chang; David W Gjertson; Jerzy W Kupiec-Weglinski; Elaine F Reed
Journal:  Ann Surg       Date:  2020-05       Impact factor: 13.787

6.  Serum CA19-9 as a marker of circulating tumor cells in first reflux blood of colorectal cancer patients.

Authors:  Jia-Xing Zhao; Zhong-Guo Zhang; Li-Ren Liu; Xiao-Yu Yang; Fang Liu
Journal:  Oncotarget       Date:  2017-07-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.